Department of Psychiatry

June 2, 2016

Alzheimer’s risk gene in younger adults

A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age.

By Leigh MacMillan
May 12, 2016

COX-2 blocker could help PTSD

COX-2 inhibitors – used clinically to reduce inflammation and pain – may find new applications for treating PTSD and other stress-related psychiatric disorders like major depression.

By Bill Snyder
February 19, 2016

Face recognition and social anxiety

An inability to recognize faces may be an important mechanism underlying social inhibition and may contribute to, or maintain, social anxiety.

By Sanjay Mishra
February 5, 2016

Trivedi named CEO of Vanderbilt Psychiatric Hospital

Harsh Trivedi, M.D., MBA, associate professor of Psychiatry, vice chair for Clinical Affairs for Vanderbilt’s Department of Psychiatry, and executive director and chief medical officer of Vanderbilt Behavioral Health, has been named CEO of Vanderbilt Psychiatric Hospital. He will remain administrative director for Vanderbilt Behavioral Health.

By Nancy Humphrey
January 28, 2016

Autism study links sensory difficulties, serotonin system

Vanderbilt researchers have established a link between the neurotransmitter serotonin and certain behaviors of some children with autism spectrum disorder (ASD), a link that may lead to new treatments for ASD.

By VUMC News and Communications
Neurons with serotonin transporters labeled with quantum dots. (Jerry Chang / Vanderbilt)
November 5, 2015

Study further links immune response, serotonin signaling

Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior.

By Bill Snyder
October 29, 2015

Study explores nicotine patch to treat memory loss

Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease.
By Nancy Humphrey
August 27, 2015

Depression study seeks to predict treatment response

Treating depressed individuals and figuring out who will and won’t respond to antidepressants is mostly trial and error — much to the frustration of patients and the health care providers who treat them.
By Nancy Humphrey
August 21, 2015

Brain circuitry in psychosis

Functional magnetic resonance imaging has revealed faulty circuits between the thalamus – a central hub of brain activity – and other brain regions.
By Leigh MacMillan
August 20, 2015

Study seeks to ease ‘chemobrain’ for cancer patients

Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment.
By Nancy Humphrey
June 16, 2015

A view of brain function in disease

Vanderbilt investigators report the first use of a specialized type of MRI to study the hippocampus in patients with schizophrenia.
By Leigh MacMillan
February 12, 2015

Hazy definition may hamper catatonia care

Catatonia, a syndrome characterized by muscular rigidity and a trance-like mental stupor, can at times manifest with great excitement and confusion. And while it is often associated with schizophrenia, it can present in patients with either medical or psychiatric conditions. For this reason, the condition has often confused clinicians.
By Nancy Humphrey
December 18, 2014

Family’s gift bolsters schizophrenia research, treatment

A “transformational” $6.4 million gift from Dallas couple Donald Test Jr., and his wife, Charlotte, who have a very personal connection to the devastating disease of schizophrenia, is supporting Vanderbilt Department of Psychiatry research and treatment into schizophrenia and related disorders.
By Nancy Humphrey
1 … 4 5 6 7 8 9